ETPharma.com·2 min read·medium
Moderna partners with global health coalition to develop Bundibugyo Ebola vaccine
✦AI Summary
Moderna has partnered with the Coalition for Epidemic Preparedness Innovations to develop a vaccine for the Bundibugyo Ebola virus. The initiative is supported by $50 million in funding to address the ongoing outbreak in the Democratic Republic of Congo.
Why it matters
Accelerated vaccine development is critical to containing the Ebola outbreak, which has already caused significant casualties in the region.
Moderna partners with global health coalition to develop Bundibugyo Ebola vaccine
healthsciencebusiness
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 95%
The article is a straightforward business and health report on vaccine development funding.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in